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1. ABSTRACT
    Based on available DNA sequence data in the
HLA region of 4 Mb, we review the degree of
polymorphism at 39 loci of which most are involved in the
immune system.  The extent of nucleotide differences per
silent site differs greatly from locus to locus.  It is
exceptionally high at classical MHC loci, intermediate at six
MHC-related pseudogenes as well as at some loci in class I
and II regions, and low in the class III region.  Different
exons of individual MHC loci show also different degrees of
silent polymorphism; high in the exons encoding for the
peptide binding region (PBR) and low in the exons ncoding
for trans-membranes and cytoplasmic tails.  The degree of
polymorphism within MHC allelic ineages is not much
smaller than that between allelic lineages, contrary to the
expectation where intra-allelic sequence exchanges are
restricted.  The observation that many allelic lineages at the
HLA-DRB1 locus are combinations of distinct motifs in the
beta pleated sheet and alpha helix of PBR indicates that
sequence exchanges occur even within exon 2.  Semi-
quantitative analysis is presented about the rate of sequence
exchanges between selected and linked neutral regions,
although more sequence information is necessary to make
definite conclusions.  The extraordinary MHC
polymorphism is viewed from the dual function of MHC
molecules that controls the acquired immune system.
2.  INTRODUCTION
The pattern and degree of polymorphism across
the genome are a useful indicator for identifying genes or
genomic regions which are subjected to different types of
natural selection.  In some circumstances, polymorphism
may also be used to infer the function of unknown genes.
Without the action of natural selection, polymorphism
(often measured by the pairwise nucleotide differences at
the DNA level) must have evolved in much the same way
as what the neutral theory of molecular evolution depicts
(1, 2):  The larger the effective population size (Ne) and the
higher the neutral mutation rate, the more polymorphic.  In
genomic regions experiencing either positive or negative
selection (purifying selection), polymorphism is lowered
(3, 4), while in those experiencing diversifying or balancing
selection, it is enhanced (5-9).  These contrasting effects of
natural selection are not necessarily confined in the target
region per se, but they should be manifest also in a
neighboring genomic region in linkage.  An important
factor is obviously the rate (c) of recombination between
two linked regions under study (5, 9).
A pair of neutral genes in an autosomal region
segregate for 2Ne generations on average (10), so that if
recombination occurs rarely or at rate c = 1/Ne or less with
the target region of natural selection, the linked neutral
polymorphism will be affected (11).  Since Ne is estimated
as about 104 for the human population over the past one
million years (7, 12), the indirect effect of natural selection
extends to the neighboring region with c £ 0.01% or
physical map distance £ 10 kb if 1 cM = 1 Mb (13).  Thus,
if reduced polymorphism is observed in a neutral region,
purifying selection might have occurred somewhere in the
surrounding left or right 10 kb region during a much shorter
period of time than the last 2  ´ 104 generations.  On the
other hand, if enhanced polymorphism is observed,
balancing selection might have been operating throughout a
much longer period of time than 2  ´ 104 generations.  In
this case, the candidate region may be broader than of 20 kb
because the efficiency of recombination is reduced in
proportion to the number of alleles that are maintained by
balancing selection (9).
In humans, the nucleotide differences are
0.08% over 18,844 silent (synonymous) sites for 48 pairs
of carefully checked autosomal sequences ("standard") (12,
14).  For 12 additional pairs of unchecked sequences (14),
the silent differences become high (0.31% over 6,071 sites),
yet they are much smaller than 1%.  Although no
comparable estimates except for mitochondrial DNA are
available in non-human primates (15), the silent differences
(1.3% on average) in Drosophila melanogaster and its
sibling species suggested that the degree of DNA
polymorphism in humans is exceedingly low (14).
Notwithstanding, the silent differences at some functional
HLA class I and II loci are 50 to 100-fold greater than the
standard (16).  Convincing evidence accumulated to support
the notion that this results from the long lasting operation
of balancing selection for non-silent substitutions in the
peptide binding region (PBR) of major histocompatibility
complex (MHC) molecules (17 - 20).
This review first summarizes the polymorphism
at 39 loci dispersed in the HLA region of 4 Mb; some are
MHC proper or their pseudogenes and others encode for
proteins involved in the immune system.  Second, the silent
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Figure 1.  The silent nucleotide differences (ps) and
chromosomal locations of 39 loci in the HLA region of 4
Mb (41 - 43).
differences at a particular locus are plotted against the
physical map distance from the nearest highly polymorphic
MHC locus and this relationship is used to examine semi-
quantitatively whether 1 cM = 1 Mb holds true in the HLA
region.  Third, the silent differences within and between
class II DRB1 allelic neages are presented to discuss the
possibility of intra-exonic recombination or gene conversion
(21 - 23).  Relevant multi-locus haplotype data from
Siberian populations (24) are briefly mentioned.   Finally,
we provide short comments on MHC-mediated thymic
selection in T cell repertoire and some perspectives for the
HLA study.
3.  GENES AND NUCLEOTIDE DIFFERENCES IN
HLA
The degree of polymorphism at 39 loci in HLA is
summarized in table 1 in terms of the average number of
nucleotide differences and the number of segregating sites at
both silent (Ss) and non-silent sites (Sn).  It is clear that the
degree differs greatly from locus to locus (figure 1).
Without direct and indirect effects of natural selection, the
silent polymorphism should be relatively uniform over the
loci, while the non-silent polymorphism may vary from
locus to locus owing to different degrees of functional
constraints (2).  Nevertheless, the non-silent as well as
silent polymorphism at classical class I or class Ia (A, B
and C) and class II (DPB1, DPA1, DQB1, DQA1, DRB1
and DRA) loci is enhanced considerably from the standard
value of 0.08%.  The overall silent differences (ps) at these
class Ia and II loci are 3.37% and 4.20% per site,
respectively.  If the neutral mutation rate is 10-9 p r ite per
year (25), it must have taken about 20 million years or
some millions of generations for these silent differences to
have accumulated.  The different GC content in the HLA
region may well affect the neutral mutation rate, but this
does not seem sufficient to account for the observed
heterogeneity in the extent of polymorphism.  No doubt,
the enhanced silent polymorphism has resulted largely from
the action of balancing selection on the PBR and its indirect
effects on tightly linked silent sites.  The overall non-silent
polymorphism is also as great as the silent polymorphism.
The absence of any appreciable difference between silent
and non-silent polymorphism of MHC genes is similar to
what is expected for pseudogenes (2), but for very different
reasons.
The remaining 30 include immunity-related loci in
addition to two class I and four class II pseudogenes in
which all nucleotide sites are treated as silent.  The overall
ps value at these 30 loci reduces to 127/15,132 = 0.84%.
Yet, it is ten-fold larger than the standard (P < 0.01).  Also,
the ps value of 1.2% over the four class II p eudogenes
(DPB2, DQB2, DQA2 and DQB3) is much greater than the
standard (P < 0.01).  This enhancement may be due to
recent cessation of balancing selection, inter-locus sequence
exchanges (unequal crossover or gene conversion), or tight
linkage to classical class II loci.  The first possibility is
unlikely because the presence of DPB2 or DQB2 thologs
in various primates (26) suggests that the two loci were
inactivated long before their alleles were generated.  The
second possibility is inconsistent with the monophyletic
relationships between these pseudogenes and functional
paralogs (26); with inter-locus sequence exchanges, the
relationships must be para- or polyphyletic.  Thus, the
relatively large ps value for these pseudogenes is attributed
to indirect effects of balancing selection operating on nearby
polymorphic class II loci.
The LMP2 and LMP7 genes encode for subunits
of a proteasome, while the TAP1 and TAP2 genes encode
for ABC transporter proteins, all being involved in
processing of proteins into peptides that are loaded onto
class I molecules (27).  Unlike the rat TAP ortholog (28,
29), these four loci in HLA are rather monomorphic:  The
ps value of 0.19% over the 1,492 silent sites is not different
from the standard.  The DNA and DOB genes as well as
DMA and DMB genes encode for alpha and beta
polypeptide chains, respectively, each pair of chains
forming heterodimers like classical class II chains (30 - 32).
The function of the DM heterodimer is thought to facilitate
the exchange of class II associated invariant chains for
peptides that are generated in lysosomes from self and non-
self proteins (33), while the DO heterodimer inhibits such a
catalytic action of DM (34, 35). The average ps v lue at
these loci is 0.46%.  Because of the small number of sites
compared (549 bp), the difference of ps = 0.46% from the
standard is only marginally significant (0.05 < P < 0.1).
 
Among 13 loci in the class III region, CYP21B
(steroid 21-hydroxylase involved in biosynthesis of cortisol
and aldosterone) and HSP70-2 (the major heat-inducible
chaperone of the HSP70 group) are shown to have
undergone frequent sequence exchanges with nearby
paralogs (36, 37).  As a result, the nucleotide differences are
rather large so that in what follows, these two loci are
excluded from consideration.  In the remaining 11 loci, the
average ps value of 0.22% at 3,329 sites is not different
from the standard.  However, the non-silent differences (pn)
of 0.24% are greater than 0.024% at the standard loci (P <
0.01).  It turns out that MICA (MHC class I chain-related
A) is unusual in that among 16 alleles at the locus, there are
22 non-silent segregating sites out of 618 and the alleles are
different from each other by seven such sites on average.
The MICA and MICB genes encode for non-classical (or
class Ib) MHC molecules (38 - 41) and may be recognized
mainly in intestinal epithelium by T lymphocytes with
gamma-delta T cell receptors (Tcr) (42).  The significantly
large pn value of MICA may be associated with               
this putative function.  The class III region                     
also         encodes for several other immunity-related genes
(27) such as in the complement cascade (C4B, Bf) and the
regulation of T lymphocyte development and function
(TNF).
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Table 1. The per-site nucleotide differences (p) and the number of segregating sites (S) over L sites at each of 39 loci in the HLA
coding region.
Locus Silent Non-silent References
(#genes) Ks /Ls = ps (%) Ss Kn /Ln= pn (%) Sn or accession numbers
1 DPB2 (2) 37/1977 = 1.9 37 – – (73), (74)
2 DPB1 (67) 1/63 = 1.6 6.5 9.1/191 = 4.8 24.5 (47)
3 DPA1 (8) 3.5/59 = 5.9 8.7 5.2/185 = 2.8 12.3 (47)
4 DNA (3) 2/204 = 1.0 3 0/547 = 0 0 M31525, M26039, X02882
5 DMA (4) 0/71 = 0 0 3/208 = 1.5 6 X62744, X76775, U04878, U04877
6 DMB (7) 0.5/60 = 0.83 2 2/177 = 1.1 5 Y14395, U00700, U31743, AF00482, U16762, U32663, X76776
7 LMP2 (3) 0.5/173 = 0.24 1 0.4/463 = 0.09 1 X62741, S75169, U01025
8 TAP1 (5) 0.3/631 = 0.05 1 1.8/1610 = 0.11 4 X57522, L21205, L21206, L21207, L21208
9 LMP7 (5) 0/172 = 0 0 0/509 = 0 0 X62598, L11045, U17496, U17497, X66401
10 TAP2 (3) 2/516 = 0.39 3 2/1350 = 0.15 3 U07844, Z22935, Z22936
11 DOB (2) 0/214 = 0 0 1.2/605 = 0.17 1 M26040, L29472
12 DQB2 (8) 1.4/201 = 0.69 3 – – M83889, M83890, M83891, M24921, M24920, M24922,
M24923, M95729
13 DQA2 (2) 21/2504 = 0.84 21 – – Z84490, M29615
14 DQB3 (2) 15/1407 = 1.1 15 – – Z84490, M26577
15 DQB1 (27) 6.2/73 = 8.6 17.5 17/212 = 8.1 42 (47)
16 DQA1 (15) 9.0/150 = 6.0 26.5 19/426 = 4.5 47.5 (47)
17 DRB1 (135) 3.6/60 = 6.0 24 12/183 = 6.5 55.5 (47)
18 DRA (2) 1/174 = 0.57 1 1.0/504 = 0.20 1 (47)
19 PBX-2 (3) 0/338 = 0 0 0.7/953 = 0.07 1 X59842, X80700, D28769
20 RAGE (2) 0.5/338 = 0.15 0.5 3.5/874 = 0.40 3.5 M91211, D28769
21 G13 (2) 2/578 = 0.35 2 3/1520 = 0.20 3 X98054, U89337
22 CYP21B (2) 5/405 = 1.23 5 3/1080 = 0.28 3 M31022, AF019413
23 C4B (2) 1/310 = 0.32 1 1/833 = 0.12 1 K02404, AF019413
24 G11 (2) 0/214 = 0 0 0/560 = 0 0 X77836, (75)
25 RD (4) 1.5/274 = 0.54 3 2.6/778 = 0.33 5 L03411, M32275, X16105, AF019413
26 Bf (2) 0/467 = 0 0 1/1350 = 0.07 1 X72875, AF0149413
27 HSP70-2 (2) 7/508 = 1.4 7 2/1410 = 0.14 2 M59830, M11717
28 TNF (3) 0/191 = 0 0 0.7/508 = 0.13 1 X01394, X02910, M10988
29 BAT1 (3) 0/211 = 0 0 0.7/639 = 0.11 1 Z37166, AF029062, A02961
30 MICB (7) 0.3/204 = 0.14 1 1.7/618 = 0.28 6 (36), (37)
31 MICA (16) 2/204 = 0.96 5 7.2/618 = 1.2 22 (38), (39)
32 B (91) 9.7/289 = 3.4 45.4 25/796 = 3.2 91.5 (48)
33 C (35) 8.3/281 = 3.0 46.8 18/779 = 2.3 89.8 (48)
34 SC1 (2) 0/301 = 0 0 8/767 = 1.0 8 S53374, U25826
35 E (5) 0.5/127 = 0.43 3 1.8/346 = 0.51 6 (76)
36 J (3) 7.5/1046 = 0.72 11 – – (76)
37 A (50) 10/261 = 3.8 38 25/758 = 3.3 90.5 (48)
38 H (6) 18.7/1091 = 1.71 45 – – (76)
39 G (6) 1.1/195 = 0.56 5 1.3/522 = 0.25 4 (76)
The K and L are the average number of nucleotide differences and the average number of sites in all pairwise comparisons,
respectively, and the subscripts stand for silent and non-silent nucleotide substitutions.
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Figure 2.  The observed silent nucleotide differences at
individual loci are plotted against the physical map distance
from the nearest highly polymorphic HLA locus.  The solid
and dotted curves are computed by the theoretical formulas
(9, 45) under the assumption of 1 cM = 1 Mb and 0.1 cM
= 1 Mb, respectively.  It is assumed that selection intensity
is 2% and the number of breeding individuals is 105 and 104
before and after 50,000 generations ago.  The values of the
per-site neutral mutation rate and the non-silent
substitutions rate per PBR per generation are given in text.
The discrepancy from the 1 cM = 1 Mb curve is caused by
MICA, J, H and G or by DPB2, DQB3, DNA, DQA2 and
DQB2.
The average ps value over five loci (SC1, E, J, H
and G) in the class I region is 0.98% which is greater than
the standard (P < 0.01).  The SC1 gene is thought to control
the cell cycle, while the E and G genes encode for class Ib
molecules.  The relatively high ps value in the class I region
is largely attributable to processed pseudogene HLA-H (not
to be confused with the renamed gene (HFE) that is
responsible for hereditary hemochromatosis (43), more than
3 Mb telomeric from the HLA).  Compared with the case of
HLA-J which is also a pseudogene, both ps= 1.7% and Ss =
43 over 1,067 silent sites at the HLA-H locus appear to be
too large.  However, there is evidence that a telomeric region
of the HLA-A locus is somewhat suppressed in
recombination (H. Inoko, personal communication).
Although the reason is poorly understood, the reduced
recombination may well account for the elevated
polymorphism at the HLA-H locus as well as the slightly
increased polymorphism at the HLA-G locus.
4.  INTERGENIC RECOMBINATION
              In order to study the relationships between
silent differences (ps) and recombination rates (c), each ps
value is plotted against the physical map distance (44 - 46)
which is measured from the nearest highly polymorphic
HLA locus (figure 2).  As expected, the longer the distance,
the smaller the ps value.  The following theoretical model (9,
47, 48) is used to examine the relationships more
quantitatively.  The model assumes that the neutral region
and the PBR encoding exon are recombined with rate c per
generation.  The model also assumes that any PBR non-
silent nucleotide substitution always generates a new allelic
lineage which, together with all other pre-existing alleles, is
subjected to random genetic drift and balancing selection.
The mutation rate per PBR is assumed to be 2.7  ´10-6 for
class I and 0.8  ´ 10-6 for class II locus owing to the
difference in the number of non-silent sites (25).  The per-
site mutation rate is 2 ´ 10-8 per generation and the
generation time is 20 years.  If a population has not been
demographically stable over time, Ne is dependent of a time
period during which polymorphism has been generated (9).
This time period for neutral polymorphism is relatively
short, while that for HLA polymorphism is relatively long.
The estimate of Ne = 104 is made based on the short-lived
neutral polymorphism, whereas that of Ne = 105 is made
based on the enhanced polymorphism due to long-lived
HLA allelic lineages (7).  The reduction in the effective
population size might have begun when Homo erectus first
migrated from Africa about one million years ago (7, 9, 48),
although there are alternatives.  Figure 2 also depicts the
expected level of linked neutral polymorphism.The indirect
effect of balancing selection is remarkable in linked neutral
regions with c < 0.01%, or only within 10 kb if 1 cM =
1Mb is postulated (13).  Thus, in order to account for large
ps values by linkage, tightly linked regions must be
considered.  The relatively large ps value at DPB2, DQB3,
DNA, DQA2 and DQB2 locus as well as that at MICA, J,
H and G locus requires that the c value is smaller than
0.01% (figure 2).  Since these loci are located about 25 kb to
more than 200 kb apart from the nearest polymorphic
MHC locus (44), recombination may be rarer than expected
from 1 cM = 1 Mb.  One can claim that proper alignment
necessary for recombination between the homologous
chromosomes is hindered by highly diversified loci (49).
However, the small ps value at the remaining loci is by and
large consistent with the postulate of 1 cM = 1Mb.  In
addition, a reduction of silent polymorphism in non-PBR
coding exons at classical MHC loci indicated that
recombination is not fully suppressed even within a locus
(9).
5.  DRB1 ALLELIC LINEAGES AND DISEASE
ASSOCIATION
Long lasting allelic lineages at classical MHC loci
permit us to glean insight into molecular mechanisms of the
polymorphism, in particular roles of intra-exonic sequence
exchanges (recombination or gene conversion).  The silent
differences within (pw) and between (pb) allelic lineages are
particularly useful for this purpose.  Without sequence
exchanges among allelic ineages, the silent differences
within lineages should be much smaller than those between
lineages (figure 3). However, in the absence of information
on associations between alleles at a locus and the nearby
MHC locus, figure 3 cannot be used.  An  exception is
MHC loci themselves at which the linkage relationships
between non-PBR coding exons or introns and the PBR
coding exon are certain in some data sets (50, 51).
Both pw and pb values depend critically on the
definition of allelic lineages.  In addition to serological
methods, sequence motifs as well as phylogenetic analyses
can provide reasonable classifications of MHC allelic
lineages (9).  As an example, we  tak  a close look at
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Figure 3.  The silent nucleotide differences within (pw)
and between (p
b
) allelic lineages based on the theoretical
formulas (9, 45).  The same set of parameter values are used
as in figure 2.
the DRB1 locus at which the reported number of alleles is
about 180 and the average ps value at exon 2 is 8.0%,
amounting to the sequence divergence of 40 million years.
Based on the observation that the 5' exon 2 region encoding
for the beta pleated sheet and the 3' exon 2 region encoding
for the alpha helix are phylogenetically incongruent, it is
proposed that the chi-like sequence at codon 51-55
somehow mediates sequence exchanges (21). Recently,
DRB1 intron 1 and 2 sequences revealed that the
phylogenetic relationships are consistent with those of the
beta region, and therefore inconsistent with those of the
alpha region (22).  In terms of linkage disequilibrium, the
sequences of these introns are more strongly associated
with those in the beta region than in the alpha region.  It is
therefore suggested that the alpha region (or conversely,
though less likely, the beta+intron region) has been shuffled
among DRB1 alleles by either double crossover or gene
conversion (21 - 23).
Among 103 DRB1 exon 2 sequences available for
codon 9 through codon 86 (50), there are 28 and 45
different non-silent motifs in the beta and alpha region,
respectively.  Of these, 17 beta or 38 alpha motifs can be
characterized simply by a set of codon 11, 13, 30 and 37 or
by a set of codon 57, 67, 70, 71 and 74.  If we exclude
minor motifs which differ by single unique substitutions
only, there remain ten distinct beta and 16 alpha motifs (see
figure 4 for their relationships drawn by the phylogenetic
analysis).  Importantly, some of these distinct motifs in
each region are shared by chimpanzees, gorillas, or Old
World Monkeys (51, 53), suggesting that they are of
ancient origins.  This antiquity of sequence motifs is
consistent with the observed large ps values; 9.3% in the
alpha region and 4.4% in the beta region.
If DRB1 sequences in each region are classified
by either beta or alpha motifs, ps will be divided into pw
and pb although pb is close to ps by definition.
Theoretically, the best classification of allelic lineages may
be obtained when pb is maximized and pw is minimized.  In
the beta motif-based classification of allelic lineages, pw is
smaller than 0.1% in the beta region, which is in accord with
the expectation (figure 3), whereas pw is more than 3.8% in
the alpha region.  This contrasting pattern of pw in the two
regions becomes less conspicuous in the alpha motif-based
classification of allelic lineages (3.3% in the beta region and
1.2% in the alpha region).  This asymmetry may indicate
that the whole or partial alpha motifs have been recombined
with distinct beta motifs and that this shuffling generated an
enormously large number of DRB1 alleles (figure 5).  An
alternative is to invoke convergent evolution in alpha motifs
(52, 53).  In this respect, it is important to note that five
(two non-silent associated and three solitary) silent
substitutions in the alpha region are shared by distinct
allelic lineages defined by beta motifs (data not shown),
resulting in the elevated pw value in the alpha region.  Since
it is difficult to invoke convergence for these shared silent
substitutions, it is reasonable to conclude that new
combinations between beta and alpha motifs have been
generated by intra-exonic recombination or gene conversion
(22, 23).  Nonetheless, it should be kept in mind that if
sequence exchanges always occur at the same boundary, the
number of alleles maintained in a population becomes rather
limited (54).  Moreover, were some sequence exchanges not
allowed within the alpha region, it does become difficult to
account for the relatively large pw value even in the alpha-
based classification (23).  The shared silent substitutions
among different alpha motifs support that the tract of
sequence exchanges involving the alpha region is at variance.
This conclusion also agrees with the finding that although ps
is larger in the alpha than in the beta region, the
phylogenetic relationships in the former are more star-like
and more compact than in the latter (figure 4).
     Based on the serological classification (22), the pb
(pw) value averaged over about 20 complete DRB1
sequences becomes 8.4% (1.7%) in exon 2, 8.6% (0.07%) in
intron 1, 4.8% (0.06%) in intron 2, 6.0% (1.8%) in exon 3
and 1.3% (0.4%) throughout exon 4-6.  The extremely small
pw value in intron 1-2 (22) is due partly to the exclusion of
"recombinant" DRB1*0806 as well as partly to the
distinction between DRB1*1602 and *15011/*15021
although these alleles are regarded as identical in the present
beta motif-based classification.  More importantly, iIt may
be noted that the pb value tends to be smaller in non-PBR
coding regions and this tendency is observed at other
classical MHC loci as well (9).  Thus, even though intra-
locus recombination is rare, it might have acted so as to
decrease the level of silent polymorphism in non-PBR
coding exons.  For such reduction to be observed in non-
PBR coding regions which are located within a few
kilobases away from the PBR coding exon, the rate (c) of
ntra-exonic sequence exchanges may be of the order of
0.001%, as expected from 1 cM = 1Mb.
Interestingly, the beta and alpha motifs defined
above play distinct roles in shaping the physico-chemical
environment of peptide binding pockets of MHC molecules
(55 - 57) and that some alpha motifs are associated with
autoimmune diseases.  Rheumatoid arthritis is associated
with DR4 subtypes (58).  These MHC molecules possess a
set of amino acids (Q70R71A74 by the one letter amino
acid code) which participate in forming the P4 pocket.
According to the present classification of DRB1 allelic
lineages, this alpha motif occurs in some DR1 and DR14
subtypes as well, so that their susceptibility to the disease
is also worth being investigated.  Insulin-dependent diabetes
mellitus (IDDM) is associated with DR3/DR4 (59), while a
reduced incidence is found in associations with DR2 (60).
In this case too, the DRB1 amino acid residue implicated in
susceptibility or resistance is somehow related to the
specificity of the P4 pocket (61).  It is also reported that
tuberculoid leprosy is associated with
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Figure 4.  The relationships among the major beta or alpha
motifs of DRB1 peptide chains.  The relationships are
reconstructed from non-silent nucleotide differences in each
of the beta and alpha region.  Each circle represents one
non-silent nucleotide substitution.  Codon positions used
for the beta motifs are 11, 13, 30 and 37 and those for the
alpha motifs are 57, 67, 70, 71 and 74.
DR2 in Asia (62 - 64) and DR3 in Venezuela and Surinam
(65, 66).  Recently, an Arginine (R) or a negatively charged
amino acid (D or E) in the P4 pocket is hypothesized to be
critical to susceptibility (67).  There are only two alpha
motifs which do not have any of R, D and E in the P4
pocket: D57L67Q70K71A74 in some DRB1*04 and *14 as
well as D57I67Q70A71A74 in most of DRB1*15 and
*1309.  It is observed that charged residues at position 71
control the charge permitted in the P4 pocket, and that
peptides with charged residues in the P4 pocket are capable
of binding only if an opposing change, or no charge, is
present at position 71 (68).  The same is applied to
position 57 in relation to the P9 pocket.  This observation
based on MHC-associated disease susceptibility and the
structural characterization of MHC-peptide complexes (68)
lends itself to the biological implication for the present
motif-based classification of allelic lin ages.
6.  PERSPECTIVE
Unfortunately, the loci used are insufficient to
make an accurate estimate of recombination rate in HLA.
The present analysis shows that it is crucial to examine
regions that are tightly linked to MHC loci.  If 1 cM = 1
Mb holds true, c is 0.1% between an MHC locus and a
region 100 kb apart from it, and recombination with this c
value is too frequent for the present data set to demonstrate
slightly enhanced polymorphism by indirect effects of
balancing selection.  Sampling as well as sequencing errors
in the estimate of silent polymorphism must also be
minimized.  An alternative approach may be to use
population data of haplotypes.  When two loci are
recombined with c = 0.05%, it takes about 2,000
generations or 40,000 years for the linkage to be broken.
Recent survey of Siberian populations for class II
haplotypes showed that more haplotypes are found in
Siberian than in any other population and that most of them
have been generated by recombination since the
colonization of the subcontinent 40,000 years ago (24).
The finding of new combinations between DQA1 and
DQB1 molecules that are rarely found in other areas
indicated frequent occurrences of recombination during the
past 2,000 generations.  This is consistent with the
expected value of c = 0.02% under 1 cM = 1 Mb, since the
two loci are located 20 kb apart (44).  Thus, this kind of
population data will certainly complement DNA sequence
information.
Immunoglobulin (Ig), T cell receptor (Tcr) and
MHC genes are encoded for by multigene families (27).  A
relatively small number of loci and extremely high
polymorphism in MHC contrast with a large number of
rather monomorphic segmented genes and their somatic
rearrangements in Ig and Tcr.  It is argued that unlike other
multigene families in which concerted evolution is
commonly invoked, these immunity-related mul igene
families have undergone contraction, expansion and
subsequent diversification of loci (69 - 71).  However,
expansion and subsequent diversification of MHC loci must
be restrictive owing to the dual roles of MHC molecules;
elimination of auto-reactive T cell clones and presentation
of non-self peptides to mature T cell repertoire (72 - 74).
Because of this dual function in thymus and peripheral,
MHC could not have evolved as a multigene family
consisting of a large number of functional loci.  If
individuals express so many different MHC molecules
encoded for by a number of diversified duplicated loci,
either virtually all T cell clones will be capable of reacting
self peptides and be eliminated or the cell surface density of
particular MHC molecules will become too low to interact
with Tcr.  In either case, the immune system will be unable
to work properly.  On the other hand, appropriate amounts
of MHC diversity are necessary to deal with various
pathogens that individuals encounter (74).  With a relatively
small number of functional MHC loci, natural selection has
found its way to operate and favored polymorphism.  The
effect is by no means dramatic every generation (75) and it
is only after millions of generations of its operation that the
MHC polymorphism has become truly remarkable.  It
appears that the polymorphism is a sort of molecular
compromise in the acquired immune system which is
controlled by the dual function of MHC molecules.
Couldn't any better alternative have been invented?
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Figure 5.  Combinations between some beta and alpha
motifs that occur in DRB1 peptide chains.
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